News Industry News scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure November 03, 2015
News Industry News First Patient Enrolled in the SMILE Study, Sensible Medical Innovation's Randomized Controlled Trial (RCT) Designed to Measure ReDS™ Technology Impact on Heart Failure Rehospitalizations October 20, 2015
News Industry News AngioDynamics Announces First Patient Enrollment in RAPID Outcomes Database August 06, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015